Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Pellegrini S, Zamarian V, Landi E, Cospito A, Lombardo MT, Manenti F, Citro A, Schiavo Lena M, Piemonti L, Sordi V.

Journal title: Int J Mol Sci.

Journal publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Published year: 2022

DOI identifier: 10.3390/ijms23179699

ISSN: 1422-0067